SOHM, Inc. has signed the Manufacturing and Supply of Skincare Topical Products with New Export Customers
SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company, has signed a manufacturing and supply agreement for skincare topical products with new export customers. The company has dispatched its first initial purchase order of 7,500 units to a new Far East customer, which is expected to generate over a quarter million in revenue during 2024. SOHM's Carlsbad facility will handle production for ongoing regular orders.
The agreement covers human prescription topical treatments for skin care, acne, exfoliation, and anti-aging. SOHM plans to expand its business through private label agreements and CDMO activities with other domestic and export customers. The company aims to capture a substantial market share in 2024, building on its success with other product lines, including the recently introduced ABBIE kits.
SOHM, Inc. (OTC PINK:SHMN), un'azienda farmaceutica e biotecnologica, ha firmato un accordo di produzione e fornitura per prodotti topici per la cura della pelle con nuovi clienti esportatori. L'azienda ha spedito il suo primo ordine iniziale di 7.500 unità a un nuovo cliente dell'Estremo Oriente, il quale si prevede genererà oltre un quarto di milione di ricavi nel 2024. La struttura di Carlsbad di SOHM gestirà la produzione per ordini regolari in corso.
L'accordo riguarda trattamenti topici prescrivibili per la pelle, per la cura della pelle, l'acne, l'esfoliazione e l'anti-invecchiamento. SOHM prevede di espandere la propria attività attraverso accordi di private label e attività CDMO con altri clienti domestici ed esportatori. L'azienda punta a catturare una quota di mercato sostanziale nel 2024, costruendo sul successo delle altre linee di prodotto, inclusi i kit ABBIE recentemente introdotti.
SOHM, Inc. (OTC PINK:SHMN), una empresa farmacéutica y biotecnológica, ha firmado un acuerdo de fabricación y suministro para productos tópicos de cuidado de la piel con nuevos clientes exportadores. La empresa ha enviado su primer pedido inicial de 7.500 unidades a un nuevo cliente de Lejano Oriente, que se espera genere más de un cuarto de millón en ingresos durante 2024. La instalación de SOHM en Carlsbad se encargará de la producción para pedidos regulares en curso.
El acuerdo cubre tratamientos tópicos prescritos para la piel, para el cuidado de la piel, el acné, la exfoliación y el tratamiento antienvejecimiento. SOHM planea expandir su negocio a través de acuerdos de marca privada y actividades CDMO con otros clientes nacionales y de exportación. La empresa tiene como objetivo capturar una porción de mercado sustancial en 2024, basándose en su éxito con otras líneas de productos, incluidos los kits ABBIE introducidos recientemente.
SOHM, Inc. (OTC PINK:SHMN), 제약 및 생명공학 회사,는 새로운 수출 고객과 스킨케어 제품의 제조 및 공급 계약을 체결했습니다. 이 회사는 동아시아의 신규 고객에게 7,500개 규모의 첫 주문을 발송했습니다, 이는 2024년에 25만 달러 이상의 수익을 생성할 것으로 예상됩니다. SOHM의 칼스배드 시설은 지속적인 정기 주문의 생산을 담당할 것입니다.
이 계약은 피부 개선, 여드름, 각질 제거 및 안티에이징을 위한 의약품 처방 전문 제품을 포함합니다. SOHM은 다른 국내 및 수출 고객과 프라이빗 레이블 계약 및 CDMO 활동을 통해 비즈니스를 확장할 계획입니다. 회사는 2024년에 상당한 시장 점유율을 확보하는 것을 목표로 하고 있습니다, 최근 도입된 ABBIE 키트를 포함한 다른 제품군의 성공을 바탕으로 합니다.
SOHM, Inc. (OTC PINK:SHMN), une entreprise pharmaceutique et biotechnologique, a signé un accord de fabrication et de fourniture pour des produits topiques de soins de la peau avec de nouveaux clients exportateurs. L'entreprise a expédié sa première commande initiale de 7 500 unités à un nouveau client d'Extrême-Orient, ce qui devrait générer plus d'un quart de million de dollars de revenus en 2024. L'installation de SOHM à Carlsbad s'occupera de la production pour les commandes régulières en cours.
Le contrat couvre des traitements topiques sur prescription pour les soins de la peau, l'acné, l'exfoliation et l'anti-âge. SOHM prévoit d'élargir ses activités grâce à des accords de marque privée et des activités CDMO avec d'autres clients domestiques et exportateurs. L'entreprise vise à capturer une part de marché substantielle en 2024, en s'appuyant sur son succès avec d'autres gammes de produits, y compris les kits ABBIE récemment lancés.
SOHM, Inc. (OTC PINK:SHMN), ein Pharma- und Biotechnologieunternehmen, hat einen Herstellungs- und Liefervertrag für topische Hautpflegeprodukte mit neuen Exportkunden unterzeichnet. Das Unternehmen hat seine erste Anfangsbestellung von 7.500 Einheiten an einen neuen Kunden im Fernen Osten versandt, von dem erwartet wird, dass er 2024 über eine Viertelmillion Dollar Umsatz generiert. Die Produktionsstätte von SOHM in Carlsbad wird die Herstellung für laufende reguläre Bestellungen übernehmen.
Der Vertrag umfasst verschreibungspflichtige topische Behandlungen für die Hautpflege, gegen Akne, Peeling und Anti-Aging. SOHM plant, sein Geschäft durch Private-Label-Verträge und CDMO-Aktivitäten mit anderen nationalen und Exportkunden auszubauen. Das Unternehmen strebt an, im Jahr 2024 einen erheblichen Marktanteil zu gewinnen, und baut auf den Erfolgen anderer Produktlinien auf, darunter die kürzlich eingeführten ABBIE-Kits.
- Secured new export customer for skincare products
- Initial purchase order of 7,500 units dispatched
- Expected revenue of over $250,000 in 2024 from new customer
- Plans for business expansion through private label agreements and CDMO activities
- Aims to capture substantial market share in growing skincare market
- None.
CHINO HILLS, CA / ACCESSWIRE / July 30, 2024 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs, has announced today the dispatch of its first initial purchase order for manufacturing and supplying skincare products to a new Far East customer. The products, which include human prescription topical treatments for skin care, acne, exfoliation, and anti-aging, will be exported to Far Eastern countries.
Mr. Baron Night, CEO, revealed that negotiations with the new customer began in March 2024, culminating in an initial purchase order for 7,500 units. The company's Carlsbad facility will handle production, and the ongoing regular orders will generate significant revenue of over a quarter of million during the year 2024 from this new customer. Additionally, SOHM plans to expand its business through private label agreements and CDMO activities with other domestic and export customers. The initial order has already been dispatched by the company in the second quarter.
The new overseas customer, a skincare market pioneer, offers a range of proprietary formulations. SOHM is optimistic about capturing a substantial market share in 2024, building on its success with other product lines, including the recently introduced ABBIE kits.
"SOHM is very pleased to have received this new account and project." The skin care market has significantly increased in recent past years, and the company aims to capture significant market share through its customers. Mr. Night, CEO added.
The management continues and assures that SOHM achieves its target for higher revenue growth in 2024 compared to previous years, including our new ABBIE kits which is planned and expected in the current quarter.
About SOHM, Inc.:
SOHM is a biopharmaceutical company dedicated to developing and commercializing gene editing technologies for research, synthetic biology, and therapeutic applications. With a focus on precision medicine, SOHM aims to revolutionize the treatment of genetic diseases by providing safe, efficient, and targeted gene editing solutions. Through strategic collaborations and groundbreaking research, SOHM is at the forefront of advancing the field of gene therapy.
To learn more about SOHM, Inc., visit www.SOHM.com.
SOHM, Inc.:
Name: Baron Night, CEO/Dr. David Aguilar, COO
Email: info@sohm.com
Phone: (714) 522-6700
Safe Harbor Statement:
This news release contains "forward-looking statements," which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development-stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year and our quarterly reports uploaded from time to time on OTCMarkets.com.
SOURCE: SOHM, Inc
View the original press release on accesswire.com
FAQ
What new agreement has SOHM, Inc. (SHMN) announced?
How many units were in SOHM's (SHMN) initial purchase order for the new Far East customer?
What is the expected revenue for SOHM (SHMN) from the new Far East customer in 2024?
What types of skincare products will SOHM (SHMN) be manufacturing for the new customer?
